Use of antibody induction in pediatric renal transplantation

Current Opinion in Organ Transplantation

Volumn 13, Issue 5, 2008, Pages 495-499

  Pescovitz, Mark D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody induction; Children; Kidney transplant

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN; CALCINEURIN INHIBITOR; CIDOFOVIR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; LEFLUNOMIDE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RECEPTOR BLOCKING AGENT; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALGANCICLOVIR; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ANTIBODY PRODUCTION; B CELL LYMPHOMA; CLINICAL PROTOCOL; CLINICAL TRIAL; COMMUNITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LYMPHOMA; PEDIATRIC SURGERY; POLYOMA VIRUS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; ADOLESCENT; B LYMPHOCYTE; CHILD; DRUG EFFECT; IMMUNOLOGY; METHODOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; STEROIDS; T-LYMPHOCYTES;

EID: 60849121985     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328310b0ba     Document Type: Review

References (27)

1. Magee JC, Bucuvalas JC, Farmer DG, et al. Pediatric transplantation. Am J Transplant 2004; 5 (4 Pt 2):887-903.
2. Fryer JP, Benedetti E, Gillingham K, et al. Steroid-related complications in pediatric kidney transplant recipients in the cyclosporine era. Transplant Proc 1994; 26:91 -92.
3. Harmon W, Fine R, Alexander S, et al. NAPRTCS 2007 Annual Report; 2007.
4. Knechtle SJ. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. Pediatr Transplant 2004; 8:106-112.
5. Kovarik JM, Offner G, Broyer M, et al. A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations. Transplantation 2002; 74:966-971.
6. Savo AM, BookBK, Henson S, et al. Daclizumab rapidly saturates interleukin2 receptor-alpha (CD25) on lymph node lymphocytes in children. Transplant Proc 1999; 31:1182-1183.
7. Pescovitz MD, Knechtle S, Alexander SR, et al. Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients. Pediatr Transplant 2008; 12:447-455.
8. Sarwal MM, Vidhun JR, Alexander SR, et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003; 76:1331-1339.
9. Pedersen EB, El-Faramawi M, Foged N, et al. Avoiding steroids in pediatric renal transplantation: long-term experience from a single centre. Pediatr Transplant 2007; 11:730-735.
10. Schwartz JJ, Ishitani MB, Weckwerth J, et al. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Transplantation 2007; 84:715-721.
11. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72:13-21.
12. Delucchi A, Valenzuela M, Ferrario M, et al. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs. Pediatr Transplant 2007; 11:743-748.
13. Ellis D, Shapiro R, Moritz M, et al. Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation 2007; 83:1563-1570.
14. Kalil AC, Levitsky J, Lyden E, et al. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005; 143:870-880.
15. Funch DP, Walker AM, Schneider G, et al. Ganciclovir and acyclovir reduce the risk of posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant 2005; 5:2894-2900.
16. Shapiro R, Ellis D, Tan HP, et al. Alemtuzumab preconditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007; 7:2736-2738.
17. Pescovitz MD. Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 2006; 6 (5 Pt 1):859-866.
18. Pescovitz MD. The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantation. Pediatr Transplant 2004; 8:9-21.
19. Genberg H, Hansson A, Wernerson A, et al. Pharmacodynamics of rituximab in kidney transplantation. Transplantation 2007; 84 (Suppl 12):S33-S36.
20. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006; 354:1961-1963.
21. Yabu JM, Ho B, Scandling JD, Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008; 8:222-227.
22. 2004 North American Pediatric Renal Transplant Cooperative Study Annual Report. http://spitfire.emmes.com/study/ped/annlrept/annlrept2004.pdf (prepared by LynyaTalley PhD and Donald M. Stallein PhD).
23. Benfield MR, Tejani A, Harmon WE, et al. A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation. Pediatr Transplant 2005; 9:282-292.
24. Smith JM, Stablein DM, Munoz R, et al. Contributions of the transplant registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant 2007; 11:366-373.
25. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4:222-230.
26. Smith JM, Dharnidharka VR, Talley L, et al. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007; 2:1037-1042.
27. Puliyanda DP, Stablein DM, Dharnidharka VR. Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report. Am J Transplant 2007; 7:662-666.